Anticancer effect of involucrasin A on colorectal cancer cells by modulating the Akt/MDM2/p53 pathway
Oncology Letters · 12.04.2023 · 25 (6)
DOI: 10.3892/ol.2023.13804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 12.04.2023. Verfasst von Chengming Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, SAR 999078, P.R. China. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, SAR 999078, P.R. China.
- Faculty of Pharmaceutical Sciences, Shenzhen Institute of Advanced Technology Chinese Academy of Sciences, Shenzhen, Guangdong 518000, P.R. China.
- School of Traditional Chinese Medicine, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China.
Zitieren
APA
Wei, C., Du, J., Shen, Y., Wang, Z., Lin, Q., Chen, J., Zhang, F., Lin, W., Wang, Z., Yang, Z., & Ma, W. (2023). Anticancer effect of involucrasin A on colorectal cancer cells by modulating the Akt/MDM2/p53 pathway. Oncology Letters, 25(6). https://doi.org/10.3892/ol.2023.13804
Vancouver
Wei C, Du J, Shen Y, Wang Z, Lin Q, Chen J, et al. Anticancer effect of involucrasin A on colorectal cancer cells by modulating the Akt/MDM2/p53 pathway. Oncology Letters. 2023;25(6). doi:10.3892/ol.2023.13804
BibTeX
@article{Wei2023,
author = {Wei, Chengming and Du, Jingjing and Shen, Yunfu and Wang, Zi and Lin, Qianyu and Chen, Junhe and Zhang, Fuming and Lin, Wanjun and Wang, Zhibin and Yang, Zhuya and Ma, Wenzhe},
title = {Anticancer effect of involucrasin A on colorectal cancer cells by modulating the Akt/MDM2/p53 pathway},
journal = {Oncology Letters},
year = {2023},
volume = {25},
number = {6},
doi = {10.3892/ol.2023.13804}
}
EUVIMED